Nasdaq:US$16.31 (+0.33) | HKEX:HK$25.74 (-0.02) | AIM:£2.35 (-0.04)
Search
News & Press Releases
12345678
9
found Documents: 436
Announcements & Press Releases, Group | 4 Mar 2010

Final Results for the year ended 31 December 2009
a100304
Announcements & Press Releases, Other Ventures | 19 Jan 2010

Three more of Chi-Med's China Healthcare Division drugs added to latest China's National Medicines Catalogue
a100119
Announcements & Press Releases, Oncology / Immunology | 5 Nov 2009

Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans
a091105
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2009

Hutchison MediPharma Limited Initiates Phase I Clinical Trial of HMPL-011, Its Novel Single Chemical Drug Candidate for the Treatment of Auto-immune Diseases
a091030
Announcements & Press Releases, Other Ventures | 26 Oct 2009

Chi-Med increases ownership of its Hutchison Healthcare joint venture to 100%
a091026
Announcements & Press Releases, Other Ventures | 16 Oct 2009

Newly Published China National Essential Medicines List Reference Prices No Overall Negative Impact on Chi-Med Prices
a091016
Announcements & Press Releases, Other Ventures | 8 Oct 2009

Chi-Med announces joint venture with The Hain Celestial Group to develop natural and organic consumer products in Asia
a091008
Announcements & Press Releases, Other Ventures | 27 Aug 2009

Chi-Med's Main Drugs Included in the New National Essential Medicines List
a090827
Announcements & Press Releases, Group | 30 Jul 2009

Interim Results for the Six Months Ended 30 June 2009
a090730
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004
a090729
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn's Disease Trial for HMPL-004 Delivers Encouraging Results
a090713
Announcements & Press Releases, Group | 16 Mar 2009

Final Results for the year ended 31 December 2008
a090316
Announcements & Press Releases, Oncology / Immunology | 17 Feb 2009

Chi-Med Announces Completion of Patient Enrolment in its US Phase II Crohn's Disease Clinical Trial of HMPL-004, its Lead Anti-Inflammatory Drug Candidate
a090217
Announcements & Press Releases, Oncology / Immunology | 8 Jan 2009

HMPL-002 Clinical Update
a090108
Announcements & Press Releases, Oncology / Immunology | 23 Dec 2008

Hutchison MediPharma Limited Enters into Drug Discovery and Development Partnership With Ortho-McNeil-Janssen Pharmaceuticals, Inc.
a081223
Announcements & Press Releases, Oncology / Immunology | 21 Nov 2008

Chi-Med Expands Drug Discovery and Development Partnership With Lilly
a081121
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2008

Hutchison MediPharma wins the 2008 American College of Gastroenterology International Award
a081030
Announcements & Press Releases, Group | 6 Aug 2008

Interim Results for the Six Months Ended 30 June 2008
a080806a
Announcements & Press Releases, Other Ventures | 23 May 2008

China Healthcare Division Chi-Med increases ownership of its Hutchison Healthcare joint venture
a080523
Announcements & Press Releases, Other Ventures | 19 May 2008

Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
a080519
Announcements & Press Releases, Group | 19 Mar 2008

Preliminary Results for the year ended 31 December 2007
a080319
Announcements & Press Releases, Oncology / Immunology | 29 Feb 2008

Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate
a080229
Announcements & Press Releases, Other Ventures | 21 Jan 2008

Strong growth in China Healthcare divisionStreamlining of product range set to further improve financial performance
a080121
Announcements & Press Releases, Oncology / Immunology | 22 Nov 2007

Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
a071122
Announcements & Press Releases, Oncology / Immunology | 20 Aug 2007

Chi-Med Announces Drug Discovery and Development Agreement with Eli Lilly and Company
a070820
Announcements & Press Releases, Group | 9 Aug 2007

Interim Results for the Six Months Ended 30 June 2007
a070809
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
a070702
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
a070618
Announcements & Press Releases, Oncology / Immunology | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
a070523
Announcements & Press Releases, Group | 21 Mar 2007

Preliminary Results for the year ended 31 December 2006
a070321
Announcements & Press Releases, Other Ventures | 17 Jan 2007

Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
a070117
Announcements & Press Releases, Oncology / Immunology | 20 Nov 2006

Chi-Med and Merck KGaA Start Collaboration to Discover Novel Small Molecule Anti-Cancer Drugs
a061120
Announcements & Press Releases, Oncology / Immunology | 6 Nov 2006

Development Agreement with Procter & Gamble for the Discovery and Development of New Active Ingredients for Beauty Products
a061106
Announcements & Press Releases, Group | 9 Aug 2006

Financial Results for the Six Months Ended 30 June 2006
p060809
Announcements & Press Releases, Group | 17 Jul 2006

Trading Update
a060717
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
a060704
12345678
9